These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2106684

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Anticoagulant activity of heparin octasaccharide.
    Ototani N, Yosizawa Z.
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [Abstract] [Full Text] [Related]

  • 23. The effect of heparin on the affinity chromatography of plasminogen. Demonstration of heparin-plasminogen interaction.
    Hatton MW, Regoeczi E.
    Biochim Biophys Acta; 1975 Apr 29; 386(2):451-60. PubMed ID: 1138880
    [Abstract] [Full Text] [Related]

  • 24. Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.
    Pejler G, Söderström K, Karlström A.
    Biochem J; 1994 Apr 15; 299 ( Pt 2)(Pt 2):507-13. PubMed ID: 8172612
    [Abstract] [Full Text] [Related]

  • 25. Fractionation of heparin using antithrombin III reversibly bound to concanavalin A-sepharose.
    Denton J, Lewis WE, Nieduszynski IA, Phelps CF.
    Anal Biochem; 1981 Dec 15; 118(2):388-91. PubMed ID: 7337233
    [No Abstract] [Full Text] [Related]

  • 26. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA.
    Biochem J; 1987 Jun 15; 244(3):693-8. PubMed ID: 3446185
    [Abstract] [Full Text] [Related]

  • 27. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.
    Liang JF, Li Y, Yang VC.
    Thromb Res; 2000 Mar 01; 97(5):349-58. PubMed ID: 10709911
    [Abstract] [Full Text] [Related]

  • 28. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells.
    Fukushima M, Nakashima Y, Sueishi K.
    Invest Ophthalmol Vis Sci; 1989 Jul 01; 30(7):1576-83. PubMed ID: 2501229
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.
    Lang D, Williams T, Phillips A, Doctor VM.
    Eur J Drug Metab Pharmacokinet; 2004 Jul 01; 29(4):269-75. PubMed ID: 15726889
    [Abstract] [Full Text] [Related]

  • 30. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
    Rijken DC, de Munk GA, Jie AF.
    Thromb Haemost; 1993 Nov 15; 70(5):867-72. PubMed ID: 8128448
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P, Osima B, Parma B, Nader HB, Dietrich CP.
    J Pharmacol Exp Ther; 1982 Feb 15; 220(2):406-10. PubMed ID: 7057400
    [Abstract] [Full Text] [Related]

  • 32. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A, Björk I.
    Biochem J; 1981 Feb 01; 193(2):427-33. PubMed ID: 7305940
    [Abstract] [Full Text] [Related]

  • 33. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ.
    J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954
    [Abstract] [Full Text] [Related]

  • 34. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1996 Sep 29; 76(3):347-53. PubMed ID: 8883269
    [Abstract] [Full Text] [Related]

  • 35. One-step purification of tissue-type plasminogen activator using affinity chromatography with a special monoclonal antibody under mild conditions.
    Bos R, Berger L, Nieuwenhuizen W.
    Biochim Biophys Acta; 1992 Sep 15; 1117(2):188-92. PubMed ID: 1525179
    [Abstract] [Full Text] [Related]

  • 36. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
    Bhargava AS, Freihube G, Günzel P.
    Arzneimittelforschung; 1980 Sep 15; 30(10):1621-3. PubMed ID: 7192096
    [Abstract] [Full Text] [Related]

  • 37. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.
    Funahashi M, Matsumoto I, Seno N.
    Anal Biochem; 1982 Nov 01; 126(2):414-21. PubMed ID: 7158775
    [No Abstract] [Full Text] [Related]

  • 38. Aggregation of human neutrophils by heparin.
    Lazarowski ER, Santomé JA, Behrens NH, Sanchez Avalos JC.
    Thromb Res; 1986 Feb 15; 41(4):437-46. PubMed ID: 3961733
    [Abstract] [Full Text] [Related]

  • 39. Fractionation of heparin by affinity chromatography on covalently-bound human alpha-thrombin.
    Griffith MJ, Kingdon HS, Lundblad RL.
    Biochem Biophys Res Commun; 1978 Aug 14; 83(3):1198-205. PubMed ID: 568469
    [No Abstract] [Full Text] [Related]

  • 40. Neutralization of heparin by histone and its subfractions.
    Pal PK, Starr T, Gertler MM.
    Thromb Res; 1983 Jul 01; 31(1):69-79. PubMed ID: 6612698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.